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ABSTRACT
Phenotypes are investigated in model organisms to
understand and reveal the molecular mechanisms
underlying disease. Phenotype ontologies were de-
veloped to capture and compare phenotypes within
the context of a single species. Recently, these
ontologies were augmented with formal class defin-
itions that may be utilized to integrate phenotypic
data and enable the direct comparison of pheno-
types between different species. We have de-
veloped a method to transform phenotype
ontologies into a formal representation, combine
phenotype ontologies with anatomy ontologies,
and apply a measure of semantic similarity to con-
struct the PhenomeNET cross-species phenotype
network. We demonstrate that PhenomeNET can
identify orthologous genes, genes involved in the
same pathway and gene–disease associations
through the comparison of mutant phenotypes. We
provide evidence that the Adam19 and Fgf15 genes
in mice are involved in the tetralogy of Fallot, and,
using zebrafish phenotypes, propose the hypothesis
that the mammalian homologs of Cx36.7 and Nkx2.5
lie in a pathway controlling cardiac morphogenesis
and electrical conductivity which, when defective,
cause the tetralogy of Fallot phenotype. Our
method implements a whole-phenome approach
toward disease gene discovery and can be applied
to prioritize genes for rare and orphan diseases for
which the molecular basis is unknown.
INTRODUCTION
Animal models are used to investigate and understand the
mechanisms underlying human disease (1,2). To facilitate
the study and discovery of disease mechanisms, model
organism databases include descriptions of the phenotypes
that are associated with speciﬁc genotypes (e.g. an allelic
composition in a background strain) in a deﬁned environ-
ment. The ultimate aim of having a phenotypic description
of null mutations for every gene in an organism is cur-
rently being pursued by the mouse community through the
International Mouse Phenotyping Consortium (IMPC) (3)
using systematic knockouts of all the protein coding genes
in the mouse genome generated by the International
Knockout Mouse Consortium (IKMC) (4). With the
increasing availability of large volumes of phenotype
data, automated comparative analyses that systematically
relate and compare phenotypes within and across species
become critical if we are to maximally exploit this rich
data.
Several approaches to computational cross-species
phenotype comparison have been explored to date, some
making use of the semantic information contained in the
ontologies (5) and others, such as PhenomicDB (6), using
only lexical matching. More recently, in a predominantly
lexical approach, the National Library of Medicine’s
UMLS thesaurus (7) has been used to map the
Mammalian Phenotype ontology (MP) to human disease
concepts (8). This approach suffers from the different con-
ceptualizations of phenotype and disease in humans and
mice and does not exploit the full semantic information
contained in the relevant ontologies (2). To the best of our
knowledge, our approach is the only one which utilizes the
complete phenotypic repertoire of the organisms included
in the framework, and uses automated reasoning over all
of the phenotype ontologies to generate a representation
that can be explored through measures of phenotypic
similarity.
Biomedical ontologies are a means to capture and inte-
grate research data across domains, species and levels of
granularity. They formally specify the meaning of terms in
a vocabulary so that the nature of the data can be under-
stood and processed both by humans and machines. To
express this meaning, ontologies utilize formal languages,
i.e. languages that provide an explicit formal semantics.
An example of such a language is the Web Ontology
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and beneﬁts from a plethora of software tools and
libraries within the Semantic Web. In particular, OWL
facilitates automated reasoning to exploit non-explicit
knowledge in ontologies.
Species-speciﬁc phenotype ontologies are now well de-
veloped and are available from the OBO Foundry (10) for
human, mouse, ﬂy, worm and yeast. Mapping between
these ontologies has recently been facilitated by the devel-
opment of logical deﬁnitions for each class within them,
which use species-independent ontologies such as the
Gene Ontology (GO) to provide a common semantic
level at which they can be integrated into a single frame-
work (11,12).
The formal class deﬁnitions used are based on the
Entity–Quality (EQ) method (12). In the EQ method, a
phenotype is characterized by an affected Entity (from an
anatomy or process ontology) and a Quality [from the
Phenotype And Trait Ontology (PATO)] that speciﬁes
how the entity is affected (11). The affected entity can
either be a biological function or process as speciﬁed in
the GO (13) or an anatomical entity. Anatomical entities
are commonly speciﬁed in terms of a species-speciﬁc
anatomy ontology. To systematically relate classes in
species-speciﬁc anatomy ontologies, the metazoan,
species-independent UBERON ontology (12) is used to
obtain mappings between classes in species-speciﬁc
anatomy ontologies.
We describe a method that enables a whole-phenome
approach to comparative phenomics and its application
to disease gene discovery. Our method requires the for-
malization of anatomy and phenotype ontologies so that
they can be integrated using the parthood relation. We
have then generated a single, uniﬁed and logically consist-
ent representation of phenotype data for multiple species
annotated to the species-speciﬁc phenotype ontologies
within our framework, which is amenable to automated
reasoning. We make the resulting ontology and the
software used to generate it freely available.
We apply this approach to generate PhenomeNET, a
cross-species network of phenotypic similarity between
genotypes and diseases. Based on the semantically and
logically consistent cross-species ontology created
through our method, we incorporate the phenotype anno-
tations which are available in the mouse, zebraﬁsh, ﬂy,
yeast and worm model organism databases. We further
include the human phenotypes associated with inherited
diseases in the Online Mendelian Inheritance in Man
(OMIM) database (14) in the ontology. As a result, we
obtain an ontology of more than 275000 classes and more
than a million axioms. This ontology includes classes for
86203 complex phenotype annotations from the model
organism databases and OMIM. Our approach is exten-
sible in that further phenotype ontologies can be added,
and updated phenotype or disease annotations can easily
be incorporated within the same model.
The comparison of phenotypes has been shown to
predict orthologous genes, genes involved in the same
pathway and genes involved in a common disease (5).
As orthologous genes tend to be associated with related
phenotypes and share common patterns of gene
expression across species (15,16), the former provides a
useful validation of the PhenomeNET approach. We use
the Kyoto Encyclopedia of Genes and Genomes (KEGG)
database (17) to quantify the performance of the network
for predicting orthology and participation of disease gene
products in a common pathway, and we use gene–disease
associations in OMIM as well as disease model annota-
tions in the MGI database (18) to quantify the network’s
performance for predicting disease genes. In contrast to
the pairwise comparison of single genotypes and diseases,
our approach scales to whole phenomes and can enable
systematic analyses of phenotypic information. In our
evaluation of PhenomeNET, we show that mutations in
orthologous genes and genes in the same pathway have a
signiﬁcantly higher phenotypic similarity than genes that
are not orthologous or participate in the same pathway, as
previously predicted by Oti and Brunner (19) in their
concept of the modular phenotype. We further demon-
strate that PhenomeNET associates genes to diseases in
which they are known to be involved signiﬁcantly higher
than to diseases in which they are not known to be
involved. We use PhenomeNET to identify pathways
that signiﬁcantly correlate with diseases and make this
list available on our website. Furthermore,
PhenomeNET can identify novel gene–disease associ-
ations. Through manual analysis, we ﬁnd evidence that
Adam19 and Fgf15 are associated with the congenital
cardiac malformation tetralogy of Fallot in mice, and
from Zebraﬁsh phenotypes that homologs of Cx36.7 and
Nkx2.5 may be part of a pathway in mammals controlling
cardiac morphogenesis and electrical conduction whose
mutation is again associated with the tetralogy of Fallot
syndrome.
Previous approaches to disease gene prioritization often
rely on additional sources of information other than the
phenotype involved. In particular, several systems make
use of functional, pathway and literature annotations of
known diseases and disease genes to prioritize novel
disease gene candidates (20–23). However, analyses that
rely on the availability of gene annotations (such as
GO-based functional annotations) may not always
provide results when genes of unknown function are
implicated in the analysis and the pathobiology of the
disease is uncharacterized. Since PhenomeNET’s predic-
tions are based on information about phenotypes alone, it
can be applied to identify candidate genes for diseases with
an unknown molecular basis.
To allow researchers to explore PhenomeNET and use
its predictions for the prioritization of genes that may be
involved in diseases, we have made a web server available
that enables access to our results. The web server as well as
the raw data and source code we produced are freely avail-
able from http://phenomeblast.googlecode.com.
MATERIALS AND METHODS
Ontologies, software tools and libraries
We used the ontology ﬁles available for download from
the OBO Foundry website (http://obofoundry.org). The
ontology ﬁles on which we base our results were
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itions for the MP, HPO, FPO and WPO ontologies
which were obtained on 9 February 2011. The deﬁnition
ﬁle for the MP was obtained from the source code reposi-
tory at http://code.google.com/p/phenotype-ontologies/.
The deﬁnition ﬁle for the HPO was obtained from
http://www.human-phenotype-ontology.org.
Implementation
The software we produce uses the OWL API (24) and is
written in Groovy. We use the EL Vira software (25) to
convert the generated OWL ﬁles to the OWL EL subset
and enable tractable automated reasoning over the
combined ontologies. To query the ontology, we
combine the CB reasoner (26) and the CEL reasoner
(27). A part of the software is available as the
PhenomeBLAST software tool for aligning phenotypes
across species.
We implemented a novel conversion software for
phenotype ontology deﬁnitions, following the patterns
described below. The software is implemented as a script
in Groovy and available in the source code repository at
our project website. Similarly, we implement a conversion
for phenotype annotations in various model organism
databases according to our method and make the
software available in the source code repository. The
speciﬁc versions of the ontologies we used as well as
th software we generated is available on our project
website (http://phenomeblast.googlecode.com).
The ontology we created includes representations of
phenotypes associated with genotypes in the yeast,
worm, ﬂy, ﬁsh and mouse model organism databases,
disease phenotypes based on OMIM as well as the core
set of phenotype and anatomy ontologies. The resulting
ontology contains more than 275000 classes, 372000
subclass axioms, 152000 equivalent class axioms and
133 object properties, and combines the information of
ﬁve species’ phenomes as well as phenotypes of human
disease.
Phenotype annotations
We converted the phenotype annotations available in
various model organism databases. The following annota-
tion ﬁles were used:
. SGD annotations (phenotype_data.tab at http://down
loads.yeastgenome.org),
. WormBase annotations available from WormMart
(http://www.wormbase.org/biomart/martview),
. FlyBase annotations (allele_phenotypic_data_fb_
2011_01.tsv.gz at http://ﬂybase.org)
. MGI annotations (MGI_PhenoGenoMP.rpt at ftp://
ftp.informatics.jax.org/pub/reports/),
. HPO annotations of OMIM (phenotype_anno
tation.omim at http://www.human-phenotype-
ontology.org/), and
. ZFIN annotation (phenotype.txt at http://zﬁn.org/
data_transfer/Downloads/).
Phenotype representation
The basic components of the deﬁnition of a phenotype
class are a quality (Q) and an entity (E), such that the
quality inheres in the entity: Q and inheres-in some
E (12).
We observe at least four basic kinds of subclass relation
in the asserted taxonomic structure of the phenotype
ontologies. A phenotype class P1 (based on Q1 and E1)
is a subclass of the phenotype class P2 (based on Q2 and
E2), if any of the following conditions or a combination
thereof is true:
. Q1 is a subclass of Q2 and E1 is equivalent to E2; e.g.
Abdominal distention (HP:0003270) is a subclass of
Abnormality of the abdomen (HP:0001438) and both
affect the Abdomen (E) in different ways (Q);
. E1 is a subclass of E2, while Q1 and Q2 are equivalent;
e.g. Abnormality of the 3rd ﬁnger (HP:0004150) is a
subclass of Abnormality of the ﬁngers (HP:0001167),
and Middle ﬁnger (E1) is a subclass of Finger (E2);
. E1 is a part of E2 (i.e. every instance of E1 is a part of
some instance of E2) and Q1 and Q2 are equivalent;
e.g. Abnormality of the diaphragm (HP:0000775) is a
subclass of Abnormality of the abdomen (HP:0001438),
and Diaphragm is a part of the Abdomen;
. E1 is either a function of E2 or a process that realizes a
function of E2 and Q1 and Q2 are equivalent; e.g.
Hearing abnormality (HP:0000364) is a subclass of
Abnormality of the ears (HP:0000598) (28).
To reﬂect the asserted taxonomic structure of the
phenotype ontologies in their deﬁnitions and utilize the
assertion of part-hood in the anatomy ontologies for infer-
ences, we restructured the phenotype ontologies’ deﬁn-
itions to reﬂect these assumptions. When a deﬁnition is
based on an entity E and the quality class
PATO:0000001 (labelled Quality), we represent the
phenotype as
has-part some (part-of some E and
has-quality some PATO:0000001)
Furthermore, we represent phenotypes based on the entity
E and a quality Q as descriptions of the class
has-part some (E and has-quality some Q)
The use of ‘part-of’ and ‘has-part’ establishes a basic
overlap in relations between phenotype and anatomy
ontologies and permits the use of inferences made in
anatomy ontologies to infer information about
phenotypes.
Statistical testing
For each disease in OMIM, we generate a distribution 
of semantic similarity values for each gene node in the
phenotype network. We ﬁlter all disease–gene pairs in
which the gene is not present in KEGG. As a result, we
obtain a distribution  of the phenotypic similarities
of disease–gene pairs. For each KEGG pathway P,
we identify all participating genes and generate the distri-
bution P  of genes that participate in P. We then
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result is a list of P-values for each disease-pathway pair.
On this list, we applied the Holm method and the
Benjamini–Hochberg corrections for multiple testing.
We ﬁnd that PhenomeNET contains only a single,
under-annotated genotype for genes in the pathways
‘Sulfur relay system’ (ko04122), ‘Lipoic acid metabolism’
(ko00785) and ‘Indole alkaloid biosynthesis’ (ko00901).
As a result, we obtain only a single P-value for all tests
involving these pathways, and we therefore eliminate these
pathways from further analyses.
RESULTS AND DISCUSSION
Formalizing anatomy
As the ﬁrst step in our method, illustrated in Table 1 and
Figure 1, we utilize the species-independent ontology
UBERON (5,12) to construct a cross-species bridging
anatomy ontology. This cross-species ontology integrates
classes and axioms for species-independent anatomical
entities with those for species-speciﬁc anatomy ontologies.
UBERON contains species-independent anatomical
classes as well as mappings to species-speciﬁc anatomical
entities, including classes from the Foundational Model of
Anatomy (FMA) (29), Mouse Anatomy Ontology (MA)
(30), Worm Anatomy (WAO) (31), Fly Anatomy (32) and
Zebraﬁsh Anatomy (33). The mappings between
species-speciﬁc anatomy ontologies could then be used
to derive mappings between species-speciﬁc phenotype
ontologies, e.g. we use the mappings between ‘Liver’ in
MA and ‘Liver’ in FMA to derive a mapping between
the phenotypes ‘Abnormality of liver morphology’
(MP:0000598) and ‘Liver abnormality’ (HP:0001392). To
achieve this goal, we treat the mappings between
species-speciﬁc anatomical entities as statements of
equivalence between classes.
For example, UBERON provides the class ‘Islet of
Langerhans’ (UBERON:0000006) and mappings to
‘Pancreatic islet’ in human anatomy (FMA:16016) and
mouse anatomy (MA:0000127). Based on these
mappings, we declare these three classes as equivalent.
As a consequence of these classes’ becoming equivalent,
the axioms involving ‘Pancreatic islet’ in species-speciﬁc
anatomy ontologies are combined: according to the
FMA, ‘Pancreatic islet’ is part of the ‘Endocrine
pancreas’ (a kind of ‘Set of organ components’) and
the ‘Endocrine system’, according to the MA, is part of
the ‘Endocrine pancreas’ (a kind of ‘Endocrine gland’) and
part of the ‘Pancreas’. According to UBERON
‘Pancreatic islet’ is a kind of ‘Organ part’ and part of
the ‘Endocrine pancreas’. Due to further mappings in
the UBERON ontology we create cross-species equiva-
lences for ‘Endocrine pancreas, Pancreas, Endocrine
system’ and ‘Organ part’. Consequently, each of these
axioms restricts the classes in all three ontologies.
We demonstrate this integration in our framework
using the FMA, MA, WAO, ZFA and Fly Anatomy
ontologies. The result is an ontology including more
than 86000 classes in which the subsumption hierarchies
and the axioms that obtain in the species-dependent
anatomy ontologies are formally translated across all
species. Therefore, such an integrated ontology can serve
as an ‘interlingua’ across anatomy.
Removing inconsistencies
Using an OWL reasoner on this ontology allows us to
identify several thousand unsatisﬁable classes, i.e. classes
that cannot have any instance because their deﬁnition
contains a contradiction. For example, the class ‘Anus’
(FMA:15711) is a subclass of ‘Anatomical oriﬁce’
(FMA:3724) which we declare equivalent to the class
‘Oriﬁce’ (UBERON:0000161), and all these classes are
unsatisﬁable. In UBERON, ‘Oriﬁce’ is a subclass of
‘Material anatomical entity’ while ‘Anatomical oriﬁce’ is
a subclass of ‘Immaterial anatomical entity’ in the FMA.
‘Immaterial anatomical entity’ (FMA:67112) is mapped
to ‘Immaterial anatomical entity’ (UBERON:0000466)
which is declared disjoint from ‘Material anatomical
entity’ (UBERON:0000465). According to UBERON,
an immaterial anatomical entity is an anatomical entity
that has no mass while material anatomical entities
always have a mass.
Unsatisﬁable classes such as ‘Anus’ are the sub-class of
all classes in the ontology (i.e. every class in the ontology
is a super-class of or equivalent to every unsatisﬁable
class). Because all asserted sub-classes of an unsatisﬁable
class are also unsatisﬁable, a contradictory deﬁnition of a
very general class (with respect to the ontology’s
taxonomy) can result in a large number of classes
becoming unsatisﬁable. For example, because the class
‘Anatomical oriﬁce’ is unsatisﬁable, it has all classes in
our ontology as super-classes (or equivalent classes),
including ‘Tail, Caudal ﬁn’ and ‘Anus’. All asserted
sub-classes of ‘Anatomical oriﬁce’, including ‘Oral
cavity’ and ‘Anus’, will also be unsatisﬁable.
Unsatisﬁable classes can not be used to establish meaning-
ful relations between species-speciﬁc anatomical entities
within our ontology.
Due to these problems, we removed all disjointness
statements from the anatomy ontologies in order to
derive a consistent representation. As a direct consequence
of the monotonicity of ﬁrst-order logic (i.e. if a set of
axioms S is a subset of a set of axioms T, then the infer-
ences that can be drawn from S are a subset of the infer-
ences that can be drawn from T) (34), reducing an
ontology’s axioms will reduce the number of inferences
that can be drawn from it but not their nature.
Consequently, we obtain fewer inferences from the
disjointness-free module of the anatomy ontology than
could be made when the disjointness axioms are
included, but gain the advantage of being able to accur-
ately use these ontologies for reasoning. Removing the
asserted disjointness statements does not remove
the underlying conﬂicts in the conceptualization of the
anatomy ontologies and the mappings between them.
Therefore, the accurate alignment of the anatomy
ontologies is an important subject for future work. Since
the ontologies and their alignments are collaboratively de-
veloped within the OBO Foundry (10), we are working
with the ontology developers on resolving these issues.
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Based on the integrated cross-species anatomy ontologies,
we add species-dependent phenotype ontologies to our
framework in order to derive a ‘cross-species’ ontology
of phenotypes. We include the Human Phenotype
Ontology (HPO) (35), the Mammalian Phenotype
Ontology (MP) (36), the Worm Phenotype Ontology
(WPO) (37), Yeast Phenotype Ontology (APO) (38) and
the Fly Phenotype Ontology (FPO) (32) since formal def-
initions have been created for these ontologies’ classes
(11,12).
In the phenotype ontologies’ deﬁnitions, the affected
entity of a phenotype can either be an anatomical struc-
ture, a process or a function. To accommodate classes that
refer to processes or functions, we further add GO to our
combined ontology, which provides processes and func-
tions as well as additional anatomical structures (in
GO’s Cellular Component branch). Furthermore, to
specify phenotypes such as ‘Abnormal triglyceride level’
(MP:0000187) or ‘Abnormal hair cell morphology’
(MP:0000045), we include the ChEBI ontology of
chemical entities (39) and the Celltype Ontology (40).
We further modiﬁed the phenotype deﬁnitions to accur-
ately reﬂect the assumptions behind the phenotype
ontologies’ asserted taxonomic structure and interoperate
with anatomy ontologies (28, 41).
The precise formulation of phenotype classes based on
their deﬁnitions is described in the ‘Materials and
Methods’ section. The link between the phenotype
ontologies is established through species-independent
ontologies such as UBERON, GO, MPATH, ChEBI or
the Celltype Ontology, combined with the PATO ontology
of qualities. The resulting ontology, however, is more than
a combination of phenotype and anatomy ontologies: due
to axioms that relate classes in all these ontologies,
subclass relations and domain-speciﬁc axioms are
propagated across all ontologies and therefore restrict
phenotypes and anatomical entities in all species for
which we include an ontology.
Since this integrated ontology contains species-speciﬁc
classes, we can use the resulting ontology as an ‘interlin-
gua’ between human, mouse, worm, ﬁsh and yeast pheno-
types. For example, the MP class ‘Matted coat’
(MP:0003846) is mapped to the most speciﬁc
superclasses ‘Abnormality of the skin’ (HP:0000951)
and ‘Hair abnormality’ (HP:0001595) in the HPO.
Figure 2 illustrates parts of the inferences that lead to
this mapping.
Representing annotated data
The Human Phenotype Ontology is used to annotate
Mendelian diseases represented in the OMIM database
(14). We use these annotations to deﬁne classes corres-
ponding to the intersection of the HPO-based disease
phenotypes. For example, for the OMIM disease ‘Alport
Syndrome’ (OMIM:203780), we add a class to our
ontology that is deﬁned as equivalent to the intersection
of the disease’s phenotypic characteristics: ‘Renal failure’
(HP:0000083), ‘Nephritis’ (HP:0000123), ‘Hearing
loss’ (HP:0000365) and ‘Hematuria’ (HP:0000790).
The HPO classes for OMIM diseases are based on the
HPO annotations of OMIM (see ‘Materials and
Methods’ section).
Using automated reasoning in our cross-species pheno-
type framework, we obtain a rich characterization of
diseases based on classes from all the included phenotype
ontologies. For example, from the deﬁnition of the OMIM
disease ‘Alport Syndrome’ (OMIM:104200), we can
infer through automated reasoning that 57 classes from
MP characterize this disease in addition to 55 classes
from HPO, including ‘abnormal kidney physiology’
Figure 1. Overview over ontology-based data analysis. First, the
ontologies have to be formalized before their consistency can be
veriﬁed. If contradictory axioms are identiﬁed, they must be removed.
Using the ontology, biological data is represented within the same
model so that the biological questions across the data can be asked
in ﬂexible ways. If necessary, statistical approaches are applied to
complete missing information and results can then be inferred over
the combined representation.
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reﬂexes/nociception’ (MP:0002067).
The use of automated reasoning for translating repre-
sentations of disease phenotypes into a species-speciﬁc
representation is more powerful than a translation based
on mappings between the ontologies alone (41,42). OWL
reasoning on complex disease phenotype classes can utilize
inferences of additional phenotypes from complex class
deﬁnitions. For example, the class tetralogy of
Fallot (HP:0001636) is deﬁned (according to the HPO
deﬁnitions) as a phenotype of things having ‘Overriding
aorta’ (HP:0002623), ‘Ventricular septal defect’
(HP:0001629), ‘Pulmonic stenosis’ (HP:0001642) and
‘Right ventricular hypertrophy’ (HP:0001667). The
phenotype tetralogy of Fallot would automatically be
inferred to be a phenotype of an entity that is
characterized by all four individual phenotypes, i.e. if all
phenotypes that are sufﬁcient for having the disease are
available, the additional information about having the
disease is inferred.
Several model organism databases use species-speciﬁc
phenotype ontologies to formally represent phenotypes.
We can use our ontology framework to automatically
translate model organism phenotypes coded by their
cognate phenotype ontology into a human-speciﬁc repre-
sentation based on HPO. To demonstrate this application,
we include within our framework the MP-based phenotyp-
ic characterization of mouse models, the WPO-based
representation of worm phenotypes, the FPO-based
representation of ﬂy phenotypes and the APO-based rep-
resentation of yeast phenotypes. Each genotype is
represented as a class in the ontology that is deﬁned to
be equivalent to the intersection of its phenotype
annotations.
Some model organism databases do not utilize their
own species-speciﬁc phenotype ontology but rather
employ post-composed phenotype terms based on the
EQ method (11). For example, the Zebraﬁsh Model
Organism Database (ZFIN) (33) contains phenotypic
descriptions of zebraﬁsh with a particular genotype. For
this purpose, only the entity (either from GO or ZFA) and
the quality (from PATO) are recorded. Utilizing our
cross-species anatomy and phenotype ontology, we can
automatically incorporate such phenotype descriptions,
thereby enabling automatic translation of research
results across species even when no species-speciﬁc pheno-
type ontology is available. The EQ phenotypes from
ZFIN are formalized following the same approach as
the EQ-based class deﬁnitions (see ‘Materials and
Methods’ section), and we represent each genotype
annotated with a set of EQ statements as a class that is
equivalent to the intersection of the EQ-based phenotype
classes.
Cross-species phenotype representations
Based on OWL reasoning, we automatically generate a
phenotype representation based on MP, HPO, WPO,
APO and FPO for each genotype and disease annotated
using a set of phenotype classes. For example, the
zebraﬁsh genotype ZDB-GENO-091204-5 is annotated
with ‘Caudal ﬁn’ (ZFA:0000017) and the quality
‘Decreased length’ (PATO:0000574). Through inference
within our cross-species ontology framework, we obtain,
among others, the phenotype ‘Short tail’ (MP:0000592)
as a mapping of this phenotype to the MP. All
cross-species phenotype representations are available on
our website.
Constructing a cross-species phenotype network
After including classes that represent complex phenotypes
associated with either diseases or speciﬁc genotypes [i.e.
their phenoset (2)], we can investigate the relation between
these classes in the classiﬁed ontology. In particular, a
class representing a disease could be a sub- or super-class
of a class that represents a phenotype annotation of a
genotype within a model organism database. If the pheno-
types that we associate with diseases would be sufﬁcient
for having the disease (i.e. having the phenotypes would
Figure 2. Illustration of assertions and inferences about the class Matted coat. Blue-colored shapes represent qualities, gray-colored shapes represent
anatomical entities and green-colored shapes represent phenotypes. Dashed lines represent inferred associations.
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provide a formal proof for the fact) that, if a class repre-
senting a disease has sub-classes that represent genotypes,
then these genotypes are necessarily associated with the
disease. However, at least two obstacles impair the auto-
matic inference of this information: the incompleteness
of phenotypic characterization of diseases and animal
models as well as incomplete mappings between
species-speciﬁc anatomy and phenotype ontologies. To
account for incomplete information and reduce the
impact that potentially incorrect assertions have in our
framework, we explore the relation between phenotypes
using a measure of phenotypic similarity.
Using the cross-species representation of genotypes and
diseases, we construct a network in which nodes represent
phenotypes, and edges the similarity between phenotypes.
As nodes, we select all phenotypes that are associated with
a particular genotype in the mouse, worm, ﬁsh, ﬂy and
yeast model organism databases. Additionally, we add
disease nodes that are based on the phenotype associated
with a disease in OMIM. Our network contains 86203
nodes.
Since our method relies on inference over several
ontologies and complex phenotype descriptions may
refer to many nodes in these ontologies, the ontologies’
graph structure is not readily available to us for
measuring similarity. Consequently, we use the Jaccard
metric for comparing sets and assign weights to set
members based on the information content of an
ontology term (43).
We deﬁne the information content I(t) of an ontology
class t based on the probability P(X=t) that a genotype
or disease is characterized with t:
IðtÞ¼   logðPðX ¼ tÞÞ ð1Þ
The probability P(X=t) is empirically derived within
the corpus of 86203 complex phenotypes used for the
construction of the phenotype network.
Given two complex phenotypes P and R, where P is
characterized by the ontology classes Cl(P)=P1,...,Pn
and R is characterized by the classes Cl(R)=R1,...,Rm,
we deﬁne the similarity between P and R as:
simðP,RÞ¼
P
x2ClðRÞ\ClðPÞ
IðxÞ
P
y2ClðRÞ[ClðPÞ
IðyÞ
ð2Þ
sim(P,R) is the weighted Jaccard index between Cl(P)
and Cl(R). Using this metric, we perform a pairwise com-
parison of phenotype nodes in the network. We then add
the similarity measure as the weight of the edge between
two phenotype nodes. The result of applying this method
is an adjacency matrix of a cross-species phenotype and
disease network.
Phenome Browser
The Phenome Browser is a web server that allows re-
searchers to explore the PhenomeNET and its predictions.
It allows the retrieval of nodes in the PhenomeNET based
either on their name or their identiﬁer within a model
organism database. For example, the node representing
the disease ‘tetralogy of Fallot’ (OMIM:187500) can be
retrieved either through its OMIM identiﬁer
(OMIM:187500), its name or any part of its name.
Similarly, the search string ‘SSH’ can be used to retrieve
nodes representing the sonic hedgehog (SHH) gene (and
associated genotypes) in all species included in
PhenomeNET, and the search string ‘FBal0055336’ (a
FlyBase accession number) can be used to retrieve the
node representing SHH in ﬂy.
For each phenotype node, all nodes that are related
with a similarity score >0.1 can be explored. The related
nodes are presented by species and ranked according to
their similarity score. For example, exploring the node
representing ‘Sd’ (MGI:1857746) will show 76 OMIM
entries with a similarity score >0.1 (VACTERL associ-
ation with hydrocephalus (OMIM:276950) on Rank 1
with similarity score 0.23), 1422 mouse genes and geno-
types, 19 nodes representing worm genes and genotypes as
well as 40 zebraﬁsh genotype nodes. No nodes represent-
ing yeast or ﬂy phenotypes are identiﬁed with a similarity
>0.1. Each of the phenotype nodes can further be
explored in a similar way, thereby allowing to navigate
through PhenomeNET based on phenotypic relatedness
between phenotype nodes.
Evaluation
Comparison of phenotypes has been shown to predict
orthologous genes, genes involved in the same pathway
and genes involved in a common disease (5). We use the
KEGG database (17) to evaluate PhenomeNET’s per-
formance for predicting orthology and participation in a
common pathway, and we use gene–disease associations in
OMIM as well as disease model annotations in the MGI
database (18) to quantify the network’s performance for
predicting disease genes. To quantify the performance, we
create the receiver operator characteristic (ROC) curve for
the three tasks and report the area under the ROC curve
(AUC). A ROC curve is a plot of the true positive rate as a
function of the false positive rate. To generate the ROC
curve for our evaluation, we ﬁrst ﬁlter the list of associ-
ations in PhenomeNET for gene–gene and gene–genotype
associations in the case of predicting pathway and
orthology, and for gene–disease associations when pre-
dicting gene–disease associations. We then identify the
positive samples in the ranked list of the phenotype
nodes associated with each node in PhenomeNET and
treat all remaining pairs as negative samples. For
example, to evaluate PhenomeNET’s capability for pre-
dicting participation in the same pathway, we identify all
pairs of nodes that represent genes (or associated geno-
types) participating in the same pathway as positive
samples, all remaining pairs of genes as negative
samples. Based on these positive and negative examples,
we calculate the true and false positive rates based on the
rank of phenotypic similarity with which nodes are
associated in PhenomeNET. The diagonal line in a ROC
curve represents a classiﬁer that guesses randomly, and
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AUC is equivalent to the probability that a randomly
chosen positive instance is ranked higher than a
randomly chosen negative instance (44). For example,
when evaluating PhenomeNET by predicting associations
between genes in the same pathway, the AUC will be the
probability that a randomly chosen pair of genes that par-
ticipate in the same pathway have a higher score than a
randomly chosen pair of genes that do not participate in
the same pathway.
Within the phenotype network, orthologous genes have
a signiﬁcantly higher phenotypic similarity than non-
orthologous genes (AUC 0.62), genes in the same
pathway have a signiﬁcantly higher similarity than genes
that do not participate in the same pathways (AUC 0.59),
and genes have a signiﬁcantly higher phenotypic similarity
to the diseases in which they are known to be involved
than to diseases for which the involvement is not known
(AUC 0.68). Figure 3 shows the ROC curve for all three
evaluations.
In this evaluation, we assumed that gene–disease asso-
ciations that are not known to be true are false. Therefore,
the true performance of our phenotype network for pre-
dicting disease genes will likely be higher than shown in
Figure 3. For example, while the four phenotypically most
similar mouse models for tetralogy of Fallot (TOF,
OMIM:187500) are already associated with the
syndrome in the MGI, the genotype node representing
an allele of the Adam19 gene (MGI:3028702) is pheno-
typically very similar to TOF. However, while Adam19 is
known to play an essential role in cardiovascular morpho-
genesis (45), neither the gene nor the allele are currently
associated with the syndrome. Similarly, the phenotype of
an allele of Fgf15 (MGI:3044957) is highly similar to
TOF, and although Fgf15 is known to be required for
the development of the cardiac outﬂow tract (46), it has
not yet been associated with the syndrome.
We further identiﬁed pathways in KEGG that signiﬁ-
cantly overlap with diseases and make these lists available
on our project website. For example, for the TOF, we
identify the cytokine–cytokine receptor interaction
pathway (ko04060) as signiﬁcant (P=5 10
 7,
Wilcoxon signed-rank test, Benjamini–Hochberg correc-
tion). The cytokine–cytokine receptor interaction
pathway is known to be involved in embryonic heart de-
velopment (47). Another signiﬁcantly overlapping
pathway includes the TGF signalling pathway
(P=0.006, Wilcoxon signed-rank test, Benjamini–
Hochberg correction) which may result in TOF when dis-
rupted (48).
It is possible to query the network for speciﬁc pheno-
types common to one or more model organisms in order
to explore, for example, common morphogenetic
pathways. We have analyzed the set of phenotypes for
the mouse Hey2 gene (MGI:1341884), and, by
querying across the network, a mutant in the Zebraﬁsh
Cx36.7 gene (a member of the super-family of connexin
genes) was identiﬁed as the phenotypically most similar
genotype in ﬁsh (Rank 1, similarity score 0.22). While
the published description of this zebraﬁsh ENU mutant
(ftk) does not represent a classical manifestation of TOF
(which is not possible in a ﬁsh), it does include morpho-
genetic defects in the atrial and ventricular walls. The
authors noted that expression of the transcription factor
Nkx2.5 was dramatically reduced in ftk mutants and
provide evidence that, in these ﬁsh, the mutant phenotype
can be explained entirely by the action of Cx36.7 mediated
by the transcription factor Nkx2.5 (49). These candidates
for the morphological defects seen in TOF were then
examined in MGI and OMIM. While other connexins
are associated with TOF in mouse mutants, notably
connexins 40, 43 and 45 (50), there is no asserted implica-
tion in OMIM although the literature records, as with
mice, an association with connexin 43 (51). Intriguingly,
Sultana et al. (49) show that expression of the transcrip-
tion factor Nkx2.5 is dramatically decreased with loss of
the Cx36.7 gene. OMIM associates Nkx2.5 with TOF,
strongly suggesting that the two might act in a pathway
which affects heart morphogenesis (52). The linkage
between the phenotypes generated by mutations in a
connexin and Nkx2.5 has never been made for either the
human or the mouse. Further, the association between
cardiac electrical conductance and morphogenesis has
only been previously associated with the connexins (50).
This example demonstrates the power of exploring the
network of model organism phenotypes in generating
new hypotheses for gene function.
While PhenomeNET is based exclusively on informa-
tion about phenotypes, previous approaches combine
several data sources to make predictions for gene–
disease associations (20–23). In particular, many of these
systems make use of known disease genes’ ontology anno-
tations from GO or phenotype ontologies to identify genes
Figure 3. ROC curves for predicting disease, participation in a
common pathway and orthology using PhenomeNET. The ROC
curves for pathway and orthology predictions are obtained by compari-
son with KEGG, while the gene-disease predictions are derived from
OMIM and the annotated disease models in the MGI. AUC for
pathways is 0.59, for orthology 0.62 and for disease 0.68.
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these systems can predict gene–disease associations with a
signiﬁcantly higher sensitivity (i.e. true positive rate) than
PhenomeNET and these systems achieve an AUC for pre-
dicting gene–disease associations of >0.9 (20,23) (in
contrast to 0.68 for PhenomeNET). However, systems
that are based on known annotations assume that the
disease genes will be consistent with the known
pathobiology of a disease and its genetic basis, and there-
fore rely on the availability of information about the mo-
lecular mechanisms underlying a disease (23). They can
not be applied when the information about the molecular
origins of a disease is not available. Therefore, while other
gene prioritization methods can provide more accurate
predictions for candidate genes when incorporating the
molecular and functional information of known disease
genes, our method can complement these approaches as
it relies on information about phenotypes alone and can
therefore be applied when the description of the disease
phenotype is the only information available. For example,
PhenomeNET suggests the Slc34a1 gene (MGI:1345284)
as a candidate for Fanconi renotubular syndrome 1
(OMIM:134600) (Rank 2, similarity score 0.44). Slc34a1
has recently been identiﬁed as a cause of an autosomal
recessive form of Fanconi renotubular syndrome 1 (53),
and since this information is not yet available in OMIM’s
gene–disease association map, no GO-based gene priori-
tization system was able to provide predictions for this
syndrome. We make our data and source code freely avail-
able so that the developers and maintainers of other gene
prioritization systems can incorporate our method and
extend their systems.
CONCLUSION
We have developed a method to compare phenotypes
across species. We applied this method to the discovery
of disease gene candidates based on information about the
phenotype alone and could identify several novel disease
gene candidates. The prime application of the
PhenomeNET framework is to suggest candidate genes
for rare and orphan diseases without a known molecular
basis, and we provide a web server to give access to our
results. This web server can be used by researchers to
explore candidate genes for heritable diseases within the
phenotype data provided by ﬁve model organism data-
bases. Thereby, PhenomeNET can provide a means for
the analysis of phenotype data and improve the speed by
which primary research data from phenotype studies can
be translated into a better understanding of human
disease.
We intend to update the data underlying PhenomeNET
on a regular basis and make new versions available to the
scientiﬁc community when new phenotype data becomes
available or the structure, deﬁnitions or content of the
phenotype ontologies changes. Furthermore, we intend
to integrate new phenotype ontologies of different
species when they become available to extend
PhenomeNET’s coverage to further model organisms.
We plan to extend the PhenomeNET method and web
server into an analysis platform for phenotype data that
is based on real-time analyses. In such a system, scientists
would be able to describe phenotypes using a supported
phenotype ontology and explore similar phenotypes
across multiple model organism databases. The integra-
tion of other ontologies and data characterized by them,
information about genotypes, genes and gene products,
pathways and disease can enable the development of an
analysis platform for high-throughput phenotype data
that is based on the combination of ontology-based data
integration, automated reasoning and statistical and
similarity-based approaches to complete missing
information.
Our method constitutes a general approach toward
knowledge discovery with biomedical ontologies and can
be applied in all domains that apply ontologies for the
annotation of data. It further provides a means for the
qualitative evaluation and validation of both ontologies
and biological data through automated reasoning based
on the axioms and constraints provided by ontology
developers.
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